✦ LIBER ✦

BK Virus Nephropathy Developing After Renal Transplantation and Its Treatment With Ciprofloxacin: A Case Report

✍ Scribed by Cekmen, M.B.; Bakirdoven, S.; Sayan, M.; Yilmaz, A.

Book ID: 119382502
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 298 KB
Volume: 44
Category: Article
ISSN: 0041-1345
DOI: 10.1016/j.transproceed.2012.03.059

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

BK virus nephropathy after allogeneic st

BK virus nephropathy after allogeneic stem cell transplantation: A case report and literature review

✍ Lazaros J. Lekakis; Valentina Macrinici; Ioannis G. Baraboutis; Bonnie Mitchell; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 253 KB 👁 1 views

A case of second renal transplantation w

A case of second renal transplantation with acute antibody-mediated rejection complicated with BK virus nephropathy

✍ Hirokatsu Atsumi; Mitsuhiro Asaka; Shogo Kimura; Junko Imura; Keiji Fujimoto; Yo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB

Renal allograft recipient with co-existi

Renal allograft recipient with co-existing BK virus nephropathy and pulmonary histoplasmosis: report of a case

✍ Alok Sharma; Ruchika Gupta; Arvind Ahuja; Venkateswaran K. Iyer; Mitul Bora; San 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 274 KB

Simultaneous Pancreas and Kidney Transpl

Simultaneous Pancreas and Kidney Transplantation With Concurrent Allograft Nephrectomy for Recipients With Prior Renal Transplants Lost to BK Virus Nephropathy: Two Case Reports

✍ S. Kubal; J.A. Powelson; T.E. Taber; M.L. Goble; J.A. Fridell 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Epstein–Barr virus-related primary centr

Epstein–Barr virus-related primary central nervous system lymphoma after cadaveric renal transplantation improved by treatment with high-dose methotrexate followed by irradiation (Case Report)

✍ MAKOTO HIGUCHI; TAKENORI HATA; SHINO FURUYA; SHIGETOSHI HOSAKA; YUJI KAMIJO; KEN 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

Eculizumab: Safety and Efficacy After 17

Eculizumab: Safety and Efficacy After 17 Months of Treatment in a Renal Transplant Patient With Recurrent Atypical Hemolytic-Uremic Syndrome: Case Report

✍ V. Châtelet; T. Lobbedez; V. Frémeaux-Bacchi; M. Ficheux; J.Ph. Ryckelynck; B. H 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 455 KB